Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis-Reference-Cited by-同舟云学术

Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis

Author:

Mi Ze¹^ORCID,Zhang Yunshu²,Feng Zhichao¹,Liu Jiahao¹,Wu Jianmin¹,Tan Hongpei¹,Ma Xiaoqian¹,Liu Zhenguo³^ORCID,Rong Pengfei¹⁴^ORCID

Affiliation:

1. Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China

2. Xiangya School of Medicine, Central South University, Changsha, China

3. Department of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, China

4. Key Laboratory of Biological Nanotechnology of National Health Commission, Central South University, Changsha, China

Funder

National Natural Science Foundation of China

Science and Technology Project of Hunan Province

Furong Scholars Programme of Hunan Province

Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

Reference43 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献